Prospective avenues for human population genomics and disease mapping in southern Africa.


Journal

Molecular genetics and genomics : MGG
ISSN: 1617-4623
Titre abrégé: Mol Genet Genomics
Pays: Germany
ID NLM: 101093320

Informations de publication

Date de publication:
Sep 2020
Historique:
received: 13 11 2019
accepted: 06 05 2020
pubmed: 23 5 2020
medline: 7 8 2020
entrez: 23 5 2020
Statut: ppublish

Résumé

Population substructure within human populations is globally evident and a well-known confounding factor in many genetic studies. In contrast, admixture mapping exploits population stratification to detect genotype-phenotype correlations in admixed populations. Southern Africa has untapped potential for disease mapping of ancestry-specific disease risk alleles due to the distinct genetic diversity in its populations compared to other populations worldwide. This diversity contributes to a number of phenotypes, including ancestry-specific disease risk and response to pathogens. Although the 1000 Genomes Project significantly improved our understanding of genetic variation globally, southern African populations are still severely underrepresented in biomedical and human genetic studies due to insufficient large-scale publicly available data. In addition to a lack of genetic data in public repositories, existing software, algorithms and resources used for imputation and phasing of genotypic data (amongst others) are largely ineffective for populations with a complex genetic architecture such as that seen in southern Africa. This review article, therefore, aims to summarise the current limitations of conducting genetic studies on populations with a complex genetic architecture to identify potential areas for further research and development.

Identifiants

pubmed: 32440765
doi: 10.1007/s00438-020-01684-8
pii: 10.1007/s00438-020-01684-8
pmc: PMC7240165
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1079-1089

Références

Genome Res. 2007 Aug;17(8):1219-27
pubmed: 17623807
PLoS Genet. 2019 Jan 17;15(1):e1007808
pubmed: 30653506
Genome Biol. 2019 Jun 27;20(1):130
pubmed: 31248437
Genetics. 2019 Jul;212(3):869-889
pubmed: 31123038
Genome Biol Evol. 2015 Sep 11;7(9):2560-8
pubmed: 26363465
Nat Commun. 2012;3:1143
pubmed: 23072811
Nat Genet. 2019 Jan;51(1):30-35
pubmed: 30455414
Mol Biol Evol. 2020 Jan 1;37(1):18-30
pubmed: 31560401
Genet Epidemiol. 2014 Sep;38(6):502-15
pubmed: 25043967
Mol Biol Evol. 2018 Sep 1;35(9):2318-2326
pubmed: 29931083
Genomics Inform. 2012 Dec;10(4):220-5
pubmed: 23346033
PLoS One. 2017 Apr 6;12(4):e0174738
pubmed: 28384278
Am J Hum Genet. 2017 Jul 6;101(1):5-22
pubmed: 28686856
Genet Epidemiol. 2018 Apr;42(3):288-302
pubmed: 29226381
Sci Rep. 2019 Sep 25;9(1):13900
pubmed: 31554886
Am J Hum Genet. 2007 Nov;81(5):1084-97
pubmed: 17924348
Nature. 2015 Jan 15;517(7534):327-32
pubmed: 25470054
Nature. 2015 Oct 1;526(7571):75-81
pubmed: 26432246
Genet Med. 2018 Jan;20(1):159-163
pubmed: 28640241
Am J Hum Genet. 2017 Nov 2;101(5):725-736
pubmed: 29100086
Science. 2005 Oct 14;310(5746):321-4
pubmed: 16224025
Hum Mol Genet. 2014 Feb 1;23(3):796-809
pubmed: 24057671
Annu Rev Genomics Hum Genet. 2008;9:403-33
pubmed: 18593304
Science. 2017 May 5;356(6337):543-546
pubmed: 28473590
Nature. 2019 Dec;576(7785):106-111
pubmed: 31802016
Genet Epidemiol. 2019 Jul;43(5):506-521
pubmed: 30883944
PLoS One. 2013 Dec 20;8(12):e82224
pubmed: 24376522
Nat Commun. 2019 Jul 19;10(1):3195
pubmed: 31324766
Am J Hum Genet. 2004 May;74(5):965-78
pubmed: 15088268
PLoS One. 2012;7(7):e40294
pubmed: 22811759
Brief Funct Genomics. 2017 May 1;16(3):163-170
pubmed: 27436001
Pharmgenomics Pers Med. 2018 Apr 10;11:59-66
pubmed: 29692621
Proc Natl Acad Sci U S A. 2003 May 13;100(10):5896-901
pubmed: 12719533
J Hum Genet. 2016 Jun;61(6):547-53
pubmed: 26911352
Nat Genet. 2005 Feb;37(2):177-81
pubmed: 15665825
Front Genet. 2019 Feb 05;10:34
pubmed: 30804980
Curr Protoc Hum Genet. 2013;Chapter 1:Unit 1.23
pubmed: 23315925
Hum Genet. 2010 Aug;128(2):145-53
pubmed: 20490549
Front Genet. 2019 Feb 12;10:49
pubmed: 30809243
Methods Mol Biol. 2017;1666:505-525
pubmed: 28980262
Proc Am Thorac Soc. 2007 Jan;4(1):58-68
pubmed: 17202293
Genet Epidemiol. 2014 Sep;38 Suppl 1:S5-S12
pubmed: 25112189
Science. 2019 Jan 25;363(6425):
pubmed: 30679340
Nature. 2016 Oct 13;538(7624):201-206
pubmed: 27654912
Nat Genet. 1999 Jul;22(3):231-8
pubmed: 10391209
Tuberculosis (Edinb). 2014 Jul;94(4):413-20
pubmed: 24832562
Nature. 2010 Oct 28;467(7319):1099-103
pubmed: 20981099
Genome Med. 2018 Dec 27;10(1):100
pubmed: 30591078
Curr Opin Genet Dev. 2016 Dec;41:159-166
pubmed: 27810637
Science. 2020 Jan 31;367(6477):569-573
pubmed: 32001654
Genome Biol. 2019 Apr 26;20(1):82
pubmed: 31023338
Nat Genet. 1999 Jul;22(3):239-47
pubmed: 10391210
Nature. 2019 Jun;570(7762):514-518
pubmed: 31217584
Genome Biol. 2019 May 24;20(1):104
pubmed: 31126314
Brief Bioinform. 2018 Nov 19;:
pubmed: 30462157
Hum Genet. 2018 Apr;137(4):281-292
pubmed: 29637265
Mol Genet Genomics. 2017 Jun;292(3):499-509
pubmed: 28229227
Genetics. 2016 Sep;204(1):303-14
pubmed: 27474727
Curr Protoc Hum Genet. 2017 Oct 18;95:1.22.1-1.22.23
pubmed: 29044472
Nature. 2015 Oct 1;526(7571):68-74
pubmed: 26432245
Curr Opin Genet Dev. 2018 Dec;53:113-120
pubmed: 30240950
Am J Hum Genet. 2018 May 3;102(5):731-743
pubmed: 29706352
Cell. 2019 Oct 31;179(4):984-1002.e36
pubmed: 31675503
Proc Natl Acad Sci U S A. 2006 Sep 19;103(38):14068-73
pubmed: 16945910
Genome Biol. 2019 Aug 9;20(1):159
pubmed: 31399121
J Allergy Clin Immunol. 2019 Mar;143(3):957-969
pubmed: 30201514
Am J Hum Genet. 2011 Jul 15;89(1):111-20
pubmed: 21737057
BMC Genomics. 2014 Nov 25;15:1021
pubmed: 25422094
Genetics. 1991 Oct;129(2):513-23
pubmed: 1743489
Hum Mol Genet. 2019 Feb 15;28(4):675-687
pubmed: 30403821
Elife. 2016 Jun 21;5:
pubmed: 27324836
Hum Mol Genet. 2018 Aug 1;27(R2):R209-R218
pubmed: 29741686

Auteurs

Yolandi Swart (Y)

DSI-NRF Centre of Excellence for Biomedical Tuberculosis Research, South African Medical Research Council Centre for Tuberculosis Research, Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.

Gerald van Eeden (G)

DSI-NRF Centre of Excellence for Biomedical Tuberculosis Research, South African Medical Research Council Centre for Tuberculosis Research, Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.

Anel Sparks (A)

DSI-NRF Centre of Excellence for Biomedical Tuberculosis Research, South African Medical Research Council Centre for Tuberculosis Research, Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.

Caitlin Uren (C)

DSI-NRF Centre of Excellence for Biomedical Tuberculosis Research, South African Medical Research Council Centre for Tuberculosis Research, Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.

Marlo Möller (M)

DSI-NRF Centre of Excellence for Biomedical Tuberculosis Research, South African Medical Research Council Centre for Tuberculosis Research, Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa. marlom@sun.ac.za.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH